TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors
NCT03079440
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Neuroendocrine Carcinoma
Temozolomide
Capecitabine
Interventions
DRUG:
TEMCAP
Sponsor
Asan Medical Center